JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk

Advanced search
Browse by:

Department | Year

UCL Theses | Latest

Deposit your research

JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk

Mehta, P; Ciurtin, C; Scully, M; Levi, M; Chambers, RC; (2020) JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk. European Respiratory Journal , 56 (3) , Article 2001919. 10.1183/13993003.01919-2020. Green open access

[thumbnail of Chambers_2001919.full.pdf]

Preview

Text
Chambers_2001919.full.pdf - Published Version
Download (383kB) | Preview

Type:	Article
Title:	JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk
Location:	England
Open access status:	An open access version is available from UCL Discovery
DOI:	10.1183/13993003.01919-2020
Publisher version:	https://doi.org/10.1183/13993003.01919-2020
Language:	English
Additional information:	© ERS 2020 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0 (https://creativecommons.org/licenses/by-nc/4.0/).
UCL classification:	UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Respiratory Medicine
URI:	https://discovery.ucl.ac.uk/id/eprint/10105456

Downloads since deposit

62Downloads

Download activity - last month

Download activity - last 12 months

Downloads by country - last 12 months

Archive Staff Only

View Item